Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2010 Jun;117(7):788-800.
doi: 10.1111/j.1471-0528.2010.02567.x. Epub 2010 Apr 20.

What measured blood loss tells us about postpartum bleeding: a systematic review

N L Sloan  1 , J Durocher, T Aldrich, J Blum, B Winikoff
Affiliations
Free PMC article
Meta-Analysis

What measured blood loss tells us about postpartum bleeding: a systematic review

N L Sloan et al. BJOG. 2010 Jun.
Free PMC article

Abstract

Background: Meta-analyses of postpartum blood loss and the effect of uterotonics are biased by visually estimated blood loss.

Objectives: To conduct a systematic review of measured postpartum blood loss with and without prophylactic uterotonics for prevention of postpartum haemorrhage (PPH).

Search strategy: We searched Medline and PubMed terms (labour stage, third) AND (ergonovine, ergonovine tartrate, methylergonovine, oxytocin, oxytocics or misoprostol) AND (postpartum haemorrhage or haemorrhage) and Cochrane reviews without any language restriction.

Selection criteria: Refereed publications in the period 1988-2007 reporting mean postpartum blood loss, PPH (> or =500 ml) or severe PPH (> or =1000 ml) following vaginal births.

Data collection and analysis: Raw data were abstracted into Excel by one author and then reviewed by a co-author. Data were transferred to SPSS 17.0, and copied into RevMan 5.0 to perform random effects meta-analysis.

Main results: The distribution of average blood loss (29 studies) is similar with any prophylactic uterotonic, and is lower than without prophylaxis. Compared with no uterotonic, oxytocin and misoprostol have lower PPH (OR 0.43, 95% CI 0.23-0.81; OR 0.73, 95% CI 0.50-1.08, respectively) and severe PPH rates (OR 0.61, 95% CI 0.29-1.29; OR 0.74, 95% CI 0.52-1.04, respectively). Oxytocin has lower PPH (OR 0.65, 95% CI 0.60-0.70) and severe PPH (OR 0.71, 95% CI 0.56-0.91) rates than misoprostol, but not in developing countries.

Conclusion: Oxytocin is superior to misoprostol in hospitals. Misoprostol substantially lowers PPH and severe PPH. A sound assessment of the relative merits of the two drugs is needed in rural areas of developing countries, where most PPH deaths occur.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Studies reviewed and included in the meta-analyses.
Figure 2
Figure 2
Median and range of average measured blood loss by regimen used to manage the third stage of labour.
See this image and copyright information in PMC

References

    1. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PFA. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367:1066–74. - PubMed
    1. Cotter AM, Ness A, Tolosa JE. Prophylactic oxytocin for the third stage of labour. Cochrane Database Syst Rev. 2001 DOI: 10.1002/14651858.CD001808. - DOI - PubMed
    1. WHO, UNICEF, UNFPA. The World Bank World Health Organization . WHO Press, World Health Organization. Geneva: World Health Organization; 2005. Maternal mortality in 2005: estimates developed by WHO, UNICEF, UNFPA, and the World Bank; pp. 16–17.pp. 23–27.pp. 29–38. editor.
    1. UN . The Millennium Development Goals Report 2008. New York: United Nations; 2008.
    1. FIGO-ICM 2006. Prevention and Treatment of Post-partum Haemorrhage: New Advances for Low Resource Settings Joint Statement: International Confederation of Midwives (ICM), International Federation of Gynaecology and Obstetrics (FIGO)

Publication types